Status:
COMPLETED
Argon Plasma Coagulation vs Hemoclipping for Bleeding Peptic Ulcers
Lead Sponsor:
Kaohsiung Veterans General Hospital.
Conditions:
Bleeding Peptic Ulcer
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
Endoscopic treatment is recommended for initial hemostasis in nonvariceal upper gastrointestinal bleeding. However, the additional hemostatic efficacy of argon plasma coagulation (APC) has not been wi...
Detailed Description
【Goals and Background 】 Endoscopic treatment is recommended for initial hemostasis in nonvariceal upper gastrointestinal bleeding. Many endoscopic devices have been demonstrated to be effective in the...
Eligibility Criteria
Inclusion
- ． high-risk peptic ulcer bleeding. High-risk bleeding ulcers were defined as participants with stigmata of a bleeding visible vessels (eg, spurting, oozing), a non-bleeding visible vessels (NBVV) or adherent clot.4 A NBVV at endoscopy was defined as a raised red, red-blue or pale hemispheric vessel protruding from the ulcer bed, without active bleeding. An adherent clot was defined as an overlying blood clot that was resistant to vigorous irrigation.
Exclusion
- the presence of another possible bleeding site (eg, gastroesophageal varix, gastric cancer, reflux esophagitis)
- coexistence of actively severe ill diseases (eg, septic shock, stroke, myocardial infarction, surgical abdomen)
- treatment with an anticoagulant (eg, warfarin)
- pregnancy
- the presence of operated stomach
- refusal to participate in the study
Key Trial Info
Start Date :
February 9 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 25 2016
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT04366583
Start Date
February 9 2012
End Date
April 25 2016
Last Update
December 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Gastroenterology and Hepatology, Department of Internal Medicine
Kaohsiung City, Taiwan, 81362